Yakult Applies For Oxaliplatin Combination Use With Xelota
This article was originally published in PharmAsia News
Executive Summary
Yakult Honsha applied June 30 for an additional indication of combination use of Elplat (oxaliplatin) with Xelota (capecitabine) as an adjuvant treatment for stage III colorectal cancer in Japan.